NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis $1.72 -0.18 (-9.47%) Closing price 10/8/2026 04:00 PM EasternExtended Trading$1.72 +0.01 (+0.29%) As of 10/8/2026 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About IM Cannabis Stock (NASDAQ:IMCC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IM Cannabis alerts:Sign Up Key Stats Today's Range$1.67▼$1.9050-Day Range$1.63▼$4.2352-Week Range$1.55▼$77.10Volume167,493 shsAverage Volume8.52 million shsMarket Capitalization$356.04 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview IM Cannabis Corp. is a medical cannabis company that operates primarily in Israel and Germany. The company develops, imports, distributes and sells medical cannabis products through the IMC brand and related product lines. Its product portfolio includes medical cannabis flower, oils and other cannabis-based products. In Israel, IM Cannabis serves the regulated medical cannabis market through activities that include product sourcing, distribution and sales to authorized patients and pharmacies. In Germany, the company participates in the medical cannabis supply chain, including the wholesale distribution of pharmaceutical-grade cannabis products. IM Cannabis was established as an international medical cannabis operator and became publicly traded in North America in 2021. The company previously had Canadian operations but has since focused its business on its core markets in Israel and Germany. Oren Shuster has served as the company’s chief executive officer.AI Generated. May Contain Errors. Read More IM Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreIMCC MarketRank™: IM Cannabis scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingIM Cannabis has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageIM Cannabis has only been the subject of 1 research reports in the past 90 days.Read more about IM Cannabis' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about IM Cannabis' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted23.29% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.59, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently increased by 262.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest9 people have searched for IMCC on MarketBeat in the last 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by Insiders5.91% of the stock of IM Cannabis is held by insiders.Percentage Held by Institutions7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMCC Stock News HeadlinesIM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance SheetSeptember 29, 2026 | prnewswire.comIM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common SharesSeptember 24, 2026 | prnewswire.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. | Stansberry Research (Ad)IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price RequirementSeptember 23, 2026 | prnewswire.comIM Cannabis prices $1.31M registered direct offeringSeptember 23, 2026 | msn.comIM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common SharesSeptember 23, 2026 | prnewswire.comIM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS MarketSeptember 23, 2026 | prnewswire.comIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingSeptember 2, 2026 | prnewswire.comSee More Headlines IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed this year? IM Cannabis' stock was trading at $41.70 at the beginning of 2026. Since then, IMCC stock has decreased by 95.9% and is now trading at $1.72. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) posted its earnings results on Thursday, August, 13th. The company reported ($0.34) EPS for the quarter. The company earned $5.34 million during the quarter. When did IM Cannabis' stock split? Shares of IM Cannabis reverse split before market open on Friday, July 12th 2024.The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IM Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), GE Aerospace (GE) and AppLovin (APP). Company Calendar Last Earnings8/13/2026Today10/08/2026Next Earnings (Estimated)11/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, IMCC's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:IMCC CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees44Year FoundedN/AProfitability EPS (Trailing Twelve Months)($60.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$8.10 million Net Margins-39.62% Pretax Margin-40.21% Return on EquityN/A Return on Assets-58.32% Debt Debt-to-Equity RatioN/A Current Ratio0.56 Quick Ratio0.46 Sales & Book Value Annual Sales$45.80 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book Value($14.81) per share Price / Book-0.12Miscellaneous Outstanding Shares207,000Free Float195,000Market Cap$356.04 thousand OptionableNot Optionable Beta2.21 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:IMCC) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMCC Stock Alerts